Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...
A study on vector database and AI integration identifies unstable indexing, weak cross-modal fusion, and rigid resource ...
Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...
The science of gene therapy is enjoying a renaissance after ups and downs over the past 25 years. The heart of this field still largely relies on viral vector gene transfer systems that have evolved ...
Artificial intelligence-driven search and discovery startup Marqo.ai said today it has closed on an A$8 million (about $5.2 million USD) seed funding round. The lead investor in the company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results